Clinical Trial Update: TATE and KN046 in MCRC [Phase 2]

View source ↗

Summary

Phase 2 trial of TATE and KN046 in colorectal cancer with liver metastases has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• KN046
• TATE

Snippet

Sponsor: Zhejiang Raygene Pharmaceuticals Co., Ltd | Conditions: Colorectal Cancer with Hepatic Metastases | Phase 2 | Status: TERMINATED